EP2593189A2 - Compositions de conditionnement capillaire - Google Patents

Compositions de conditionnement capillaire

Info

Publication number
EP2593189A2
EP2593189A2 EP11720809.0A EP11720809A EP2593189A2 EP 2593189 A2 EP2593189 A2 EP 2593189A2 EP 11720809 A EP11720809 A EP 11720809A EP 2593189 A2 EP2593189 A2 EP 2593189A2
Authority
EP
European Patent Office
Prior art keywords
alkyl
acid
hair
alcohol
cationic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11720809.0A
Other languages
German (de)
English (en)
Inventor
Marlene Battermann
Petra Westphal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2593189A2 publication Critical patent/EP2593189A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the invention relates to hair treatment compositions containing selected alcohols and selected silicones, as well as the use of these agents for the treatment of hair.
  • these agents are formulated as a non-aerosol spray application.
  • compositions contain cyclomethicones. This means that some drugs can not penetrate deep enough or not deep enough into the hair.
  • irritation of the respiratory tract can occur at the consumer.
  • irritations can be caused by cyclomethicones and short-chain alcohols.
  • a composition with high amounts of silicone has a burdening and aggravating for the hairstyle design. A voluminous hairstyle with easy combability of wet and dry hair is not obtained with prior art compositions.
  • An object of the present invention is that to achieve the desired effect, the composition should be distributed rapidly and evenly on the treated hair. Another object is to improve the compatibility of the compositions. Another object is to further increase the conditioning effects of the conventional compositions.
  • cationic imidazolines of the 4,5-dihydro-1- (C1 to C4 alkyl) -2- (C12 to C30 alkyl) -1- (2- (C12-C30 alkyl amidoethyl) imidazolinium methosulfate type in particular those which as C1 to C4 alkyl group have a methyl, ethyl, propyl or butyl group and as C12 to C30 alkyl group independently of one another but most preferably at the same time each have an alkyl group of at least 20 C atoms, and particularly preferably 21 C atoms, when combined with silicones selected from dimethicones, dimethiconols and / or amodimethicones in a cosmetic carrier which, besides water, contains an alcohol selected from glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanedi
  • a first object of the present invention is therefore a composition for the treatment of human hair containing a) at least 0.01% by weight of a cationic imidazoline derivative of the 4,5-dihydro-1- (C 1 to C 4 alkyl) -2- (C 12 to C 30 alkyl) -1- (2- (C 12 to C 30 alkyl amidoethyl ) Imidazoliniumsalze, in particular those which have as C1 to C4 alkyl a methyl, ethyl, propyl or butyl group, and as C12 to C30 alkyl independently ofeinenader, but most preferably at the same time each an alkyl radical of at least 20 C-atoms, and particularly preferably 21 C - have atoms,
  • a cosmetic carrier comprising, in addition to water, an alcohol selected from glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol, 1, 6-hexanediol, benzyl alcohol, phenoxyethanol or mixtures thereof.
  • Hair treatment compositions for the purposes of the present invention are, for example, hair dyes, bleaching agents, hair shampoos, hair conditioners, conditioning shampoos, hair sprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations, hair lotions , Mousse, hair gels, hair waxes or combinations thereof.
  • combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber.
  • the combing work or the force used during the combing process of a fiber collective.
  • the measurement parameters can be assessed by the skilled person or quantified by measuring devices.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
  • O / W, W / O and W / O / W emulsions in the form of creams or gels or surfactant-containing foaming solutions, such as, for example, shampoos, foam aerosols or other preparations which are particularly suitable for use as cosmetic carrier c) the application on the hair are suitable.
  • the cosmetic carrier c) contains at least 50% by weight of water.
  • the cosmetic carrier c) according to the present invention contains an alcohol selected from glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol, 1, 6- Hexanediol, benzyl alcohol, phenoxyethanol or mixtures thereof.
  • the compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, ethyldiglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.
  • the alcohols are preferably selected from glycol, glycerol, benzyl alcohol and / or phenoxyethanol and mixtures thereof.
  • Particularly preferred carriers contain the selected alcohols in the following quantitative ranges: glycol of from 0.1 to 5% by weight, phenoxyethanol of from 0.1 to 5.0% by weight, preferably from 0.3 to 3.0% by weight, glycerol of 0.1 to 10 wt.%, Preferably 0.5 to 5.0 wt.% And benzyl alcohol of 0.1 to 10 wt.%.
  • Highly preferred carriers contain both phenoxyethanol and glycerol in the aforementioned ranges.
  • Highly preferred are compositions according to the invention which, in addition to the explicitly mentioned alcohols, do not contain any alcohols, such as methanol, ethanol, isopropanol, propanol or butanols.
  • the agents according to the invention contain at least one quaternary imidazoline compound, i. a compound having a positively charged imidazoline ring.
  • the imidazoline compounds of the invention are cationic imidazolines of the 4,5-dihydro-1- (C 1 to C 4 alkyl) -2- (C 12 to C 30 alkyl) -1- (2- (C 12 -C 30 alkyl amidoethyl) imidazolinium salts, especially those which as C1 to C4 alkyl group have a methyl, ethyl, propyl or butyl group, and as C12 to C30 alkyl independently but most preferably at the same time in each case an alkyl radical of at least 20 C atoms, and particularly preferably of 21 carbon atoms shows the structure of these compounds.
  • the radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of from 12 to 30 carbon atoms.
  • the preferred compounds of the formula I each contain the same hydrocarbon radical for R.
  • the chain length of the radicals R is preferably at least 20 carbon atoms. Particularly preferred are compounds having a chain length of at least 21 carbon atoms.
  • the radical R1 is a methyl, ethyl, propyl, isopropyl, butyl, isobutyl or tert-butyl group.
  • R 1 is methyl or ethyl. More preferably, R1 is a methyl group.
  • A is a physiologically acceptable anion.
  • the anionic counterion comprises halides, for example fluoride, chloride or bromide, alkyl sulfates, such as methosulfate or ethosulfate, phosphates, citrate, tartrate, maleate or fumarate.
  • alkyl sulfates such as methosulfate or ethosulfate
  • phosphates citrate, tartrate, maleate or fumarate.
  • Quaternium-91 A commercial product of this chain length is known, for example, under the name Quaternium-91.
  • the imidazolines of the formula I are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. % contain. The very best results are obtained with amounts of 0, 1 to 5 wt.%, In each case based on the total composition of the respective agent.
  • the silicone as ingredient b) according to claim 1 is selected from the group of dimethicones and / or the group of dimethiconols and / or the group of amino-functional silicones.
  • the compositions according to the invention preferably contain no cyclomethicones in addition to the selected silicones.
  • the dimethicones of the invention may be both linear and branched.
  • Linear dimethicones can be represented by the following structural formula (Sil):
  • Branched dimethicones can be represented by the structural formula (Sil 1):
  • the radicals R and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethicones are between 1000 D and 10,000,000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970.
  • Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps.
  • the most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps. By way of example, reference may be made here to the product "Dow Corning 200 with 60000 cSt.” It is most preferred according to the invention for the dimethicones of the invention to be emulsion-polymerized dimethicones.
  • Emulsion-polymerized dimethicones can be used either as a mechanical preemulsion of a dimethicone or as an emulsion of a dimethicone prepared in the emulsion polymerization process The latter is most preferred
  • An example of such highly preferred emulsions of Dimethicones obtained by the emulsion polymerization is the commercial product Dow Corning® 1664 which is also known under the name ® Xiameter MEM-1664 ..
  • dimethicones according to the invention are characterized in that they contain at least one silicone of the formula (Sil .2)
  • x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
  • the dimethicones (Sil) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5 wt.% Based on the total composition.
  • Dimethiconols according to the invention can be both linear and branched.
  • Linear dimethiconols can be represented by the following structural formula (Si8-I):
  • Branched dimethiconols can be represented by the structural formula (Si8 - II):
  • the radicals R and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethiconols are between 1000 D and 10,000,000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970.
  • Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • Examples of such products include the following commercial products: Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Coming 2-9026 Fluid, Abil OSW 5 (Degussa Care Specialties), Dow Coming 1401 Fluid, Dow Coming 1403 Fluid Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend, SM555, SM2725, SM2765, SM2785 (all four aforementioned GE Silicones), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 31 12 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).
  • Emulsion-polymerized dimethiconols can be used either as a mechanical preemulsion of a dimethiconol or as an emulsion of a dimethiconol prepared in the emulsion polymerization process. The latter is most preferred.
  • Examples of such highly preferred emulsions of dimethiconols obtained by the emulsion polymerization process are the commercial products X2-1766 and X2-1784 from Dow Corning.
  • the dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconol based on the composition.
  • Amino-functional silicones of the invention may e.g. by the formula (Si-2)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
  • Q is a polar radical of the general formula -R HZ
  • R is a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
  • Z is an organic, amino-functional group containing at least one amino-functional group
  • b takes values in the range of about 1 to about 3,
  • a + b is less than or equal to 3
  • c is a number in the range of about 1 to about 3, and
  • x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and
  • y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about
  • M is a suitable silicone end group, as is known in the art, preferably trimethylsiloxy.
  • Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for said Z is NH (CH 2 ) Z NH 2 , where z is an integer greater than or equal to 1.
  • Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) ZZ NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl.
  • Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) z (CH 2 ) zzNX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • ⁇ assumes values in the range of 0 to 2
  • b takes values in the range of 2 to 3
  • a + b is less than or equal to 3
  • c is a number in the range of 1 to 3.
  • cationic silicone oils such as, for example, the commercially available products Dow Corning (DC) 929 Emulsion, DC 2-2078, DC 5-71 13, SM-2059 (General Electric) and SLM-55067 (Wacker).
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
  • compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b)
  • R is -OH, a (optionally ethoxylated and / or propoxylated) (Ci to C 20 ) -
  • R 1 represents -OH, a (C 1 to C 20 ) alkoxy group or a -CH 3 group and
  • n and o are numbers whose sum (m + n + o) is between 1 and 2000, preferably between 50 and 150, the sum (n + o) preferably having values of 0 to 1999 and especially from 49 to 149, and m preferably takes values from 1 to 2000, in particular from 1 to 10.
  • silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example ) designated as a commercial product Silcare ® Silicone SEA Clariant available.
  • Suitable diquaternary silicones are selected from compounds of the general formula (Si3c) [RR 2 R 3 N + - A - SiR 7 R 8 - (O-SiR 9 R 0) n - O - SiR R 12 - A - N + R 4 R 5 R 6 ] 2X " (Si 3c)
  • R 1 to R 6 independently of one another are C 1 to C 22 -alkyl radicals which may contain hydroxyl groups and where preferably at least one of the radicals has at least 8 C atoms and the remaining radicals have 1 to 4 C atoms,
  • radicals R 7 to R 12 independently of one another, are identical or different and are C 1 - to C 10 -alkyl or phenyl,
  • A is a divalent organic compound group
  • n is a number from 0 to 200, preferably from 10 to 120, more preferably from 10 to 40, and X "is an anion.
  • the divalent linking group is preferably a C1 to C12 alkylene or alkoxyalkylene group which may be substituted with one or more hydroxyl groups. Particularly preferred is the group - (CH 2 ) 3-0-CH 2 -CH (OH) -CH 2 -.
  • the anion X " may be a halide ion, an acetate, an organic carboxylate or a compound of general formula RSO 3 " , wherein R has the meaning of C1 to C4 alkyl radicals.
  • Another group of amino-functional silicones are known under the INCII designations Silicone Quaternium-xx, where xx stands for a number, for example 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 18, 20, 22, etc.
  • a group of these silicone compounds is derived from the Dimethiconcopolyolen or Dimethiconolcopolyolen.
  • Dimethicone copolyols are understood according to the invention as meaning preferably polyoxyalkylene-modified dimethylpolysiloxanes of the general formulas (Si-6) or (Si-7):
  • the R radicals in these structures contain quaternary nitrogens, amino-functional radicals and / or amidoamines as quaternary radicals in the cases of the silicone quaternium-xx types.
  • the exact structures can be found in the datasheets of the manufacturers.
  • An example for Such a product is the commercial product SilSense Q Plus from the company Lubrizol.
  • Further examples are available from Dow Corning under the trade name Dow Coming 5-71 13 (Silicone Quaternium-16), Dow Corning 5-7070 (Silicone Quaternium-16 / Glycidoxy Dimethicone Crosspolymer) as well as Silquat Polyether Fatty Quats Type Siltech AD (Silicone Quaternium). 8), Silquat AC and Silquat D208, as well as silicones of the SilCare® Silicone SEA type are commercially available.
  • the anion may be a halide ion, an acetate, an organic carboxylate or a compound of the general formula RSO 3 " in which R has the meaning of C 1 to C 4 alkyl radicals.
  • Such amino-functional silicones are available under the trade designation Abilquat ® T-60 or the INCII - sold designation Silicone Quaternium-22nd
  • a preferred diquaternary silicone has the general formula (Si3d)
  • A is the group - (CH 2 ) 3 - O - CH 2 - CH (OH) - CH 2 -,
  • R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.
  • Suitable silicone polymers having two terminal quaternary ammonium groups are among
  • Preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.01 to 8% by weight, particularly preferably 0.1 to 7.5
  • the compositions according to the invention may comprise at least one polyammonium-polysiloxane compound.
  • the polyammonium-polysiloxane compounds can be obtained, for example, under the trade name Baysilone® from GE Bayer Silicones.
  • Baysilone TP 391 1, SME 253 and SFE 839 are preferred.
  • Very particular preference is given to the use of Baysilone TP 391 1 as the active component of the compositions according to the invention.
  • the polyammonium polysiloxane Compounds are present in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight, very particularly preferably from 0.05 to 2 , 5% by weight, each in relation to the total composition.
  • ester oils are used as a further particularly advantageous ingredient for the present invention.
  • the ester oils are defined as follows:
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, Gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16 18-alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ® LC)
  • n-butyl stearate oleyl erucate
  • isopropyl palmitate IPP Rilanit ®
  • oleyl Oleate Cetiol ®
  • hexyl laurate Cetiol ® A
  • di-n-butyl adipate Cetiol ® B
  • ester oils may also be alkoxylated with ethylene oxide, propylene oxide, or mixtures of ethylene oxide and propylene oxide.
  • the alkoxylation can be found both on the fatty alcohol part and on the fatty acid part and on both parts of the ester oils.
  • R 1 is a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated acyl radical having 6 to 30 carbon atoms,
  • AO is ethylene oxide, propylene oxide or butylene oxide
  • X is a number between 1 and 200, preferably 1 and 100, more preferably between 1 and 50, most preferably between 1 and 20, most preferably between 1 and 10 and most preferably between 1 and 5,
  • R 2 represents a saturated or unsaturated, branched or unbranched cyclic saturated cyclic unsaturated alkyl, alkenyl, alkynyl, phenyl or benzyl radical having from 6 to 30 carbon atoms.
  • fatty acid moieties used as radical R1 in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid , Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • fatty alcohol moieties R2 in the ester oils are benzyl alcohol, isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol , Arachylalkohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
  • a particularly preferred according to the invention is Esteröl example, under the INCI - available name PPG-3 benzyl ether myristate, for example the commercial product Crodamol STS ®.
  • ester oils are to be understood as meaning:
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides.
  • the partial glycerides preferably follow the formula (D4-I),
  • R 2 and R 3 are independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q ) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, Linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • oleic acid monoglycerides are used.
  • the ester oils are present in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight, most preferably from 0, 1 to 5.0 wt.% Used.
  • Another particularly advantageous ingredient is at least one cationically charged polymeric compound.
  • Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • the cationic polymers may be homopolymers or copolymers wherein the quaternary nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable cationic monomers are unsaturated, radically polymerizable compounds bearing at least one cationic group, especially ammonium substituted vinyl monomers such as trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium, dialkyldiallylammonium and quaternary vinylammonium monomers having cyclic cationic nitrogen containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. Alkylvinylimidazolium, Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
  • the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkyl acrylate, alkyl methacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinyl esters, for example vinyl acetate, vinyl alcohol, Propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • Suitable polymers having quaternary amine groups are the polymers described in the CTFA Cosmetic Ingredient Dictionary under the names Polyquaternium, such as methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11).
  • cationic polymers for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co. and of which the Gafquat ® 734 is particularly preferred suitable.
  • cationic polymers are, for example, Germany, marketed by the company BASF under the tradename Luviquat ® HM 550 copolymer of polyvinyl pyrrolidone and imidazolimine which ® by the company Calgon / USA under the trade name Merquat Plus 3300 sold terpolymer of dimethyldiallylammonium chloride, sodium acrylate and acrylamide and sold by the company ISP under the trade name Gafquat ® HS 100 vinylpyrrolidone / methacrylic amidopropyltrimethylammoniumchlorid copolymer.
  • R 2 , R 3 and R 4 are independently selected from C 1-4 -alkyl, -alkenyl or
  • n is a natural number
  • X is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (monomer 3) and nonionogenic monomer units are particularly preferred cationic polymers within the scope of these polymers, those are preferred for which at least one of the following conditions applies:
  • R is a methyl group
  • R 2 , R 3 and R 4 are methyl groups
  • m has the value 2.
  • Suitable physiologically tolerated counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.
  • a particularly suitable homopolymer is the
  • Such products are (3V Sigma), for example, under the names Rheocare ® CTH (Cosmetic Rheologies) and Synthalen® ® CR commercially available.
  • the homopolymer is preferably in the form of a nonaqueous polymer dispersion which has a polymer content of not less than 30 Wt .-%, used.
  • Such polymer dispersions are available under the names Salcare ® SC 95 and Salcare ® SC 96 in the trade.
  • Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives.
  • Cationic polysaccharides have the general formula (P-3) G-O-B-N + R a R b R c X
  • G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
  • B is a divalent linking group, for example alkylene, oxyalkylene, polyoxyalkylene or
  • R a , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R a , R b and R c is preferably not more than 20 is;
  • X " is a common counteranion and is preferably chloride.
  • Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol.
  • Other commercial products are the compounds Celquat ® H 100, Celquat ® L and 200.
  • a most preferred cellulose is the Polyquaternium-67. The mentioned commercial products are preferred cationic celluloses.
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar® and have the INCI name Guar Hydroxypropyltrimonium Chloride. Furthermore, particularly suitable cationic guar derivatives are also sold by the company Hercules under the name N-Hance®. Further cationic guar derivatives are marketed by Cognis under the name Cosmedia®. A preferred cationic guar derivative is the commercial product AquaCat® from Hercules. This raw material is an already pre-dissolved cationic guar derivative.
  • chitosans Another particularly suitable cationic natural polymer are chitosans.
  • quaternized, alkylated and / or hydroxyalkylated derivatives if appropriate also in microcrystalline form, are also suitable.
  • the use can also be carried out in the form of aqueous gels having a solids content in the range of 1 to 5 wt .-%.
  • a suitable chitosan is sold, for example, by the company Kyowa Oil & Fat, Japan, under the trade name Flonac®.
  • Another chitosan salt is marketed under the name Kytamer® PC by Amerchol.
  • Suitable chitosan derivatives are quaternized, alkylated or hydroxyalkylated derivatives, for example hydroxyethyl or hydroxybutylchitosan. Further chitosan derivatives are commercially available under the trade names Hydagen® CMF, Hydagen® HCMF and Chitolam® NB / 101.
  • Cationic polymers preferred according to the invention are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer® JR 400, Hydagen® HCMF and Kytamer PC, cationic guar derivatives, cationic honey derivatives, in particular the commercially available product ® Honeyquat 50th
  • These natural-based cationic polymers are contained in the compositions in an amount of 0.01 to 5% by weight, preferably 0.01 to 3.0% by weight, and more preferably in an amount of 0.05 to 3.0% by weight. % contain.
  • honey for example the commercial product Honeyquat ® 50,
  • Vinylpyrrolidone vinylimidazoliummethochloride copolymers such as those offered under the names Luviquat.RTM ® FC 370, FC 905 and HM 552,
  • Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
  • preferred cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, SoftCAT® with the INCII - designation Polyquaternium-67, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercially available product ® Honeyquat 50, cationic polymers of the type Alkylpolyglycodside and Polyquaternium-37.
  • cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons.
  • cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof.
  • the cationic protein hydrolysates may also be further derivatized.
  • cationic protein hydrolysates and derivatives As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the International Cosmetic Ingredient Dictionary and Handbook, (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products. Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.
  • the cationic polymers are contained in the compositions according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Levels of 0.05 to 5 wt .-% are particularly preferred.
  • Amphoteric polymers like the cationic polymers, are most preferred polymers.
  • Amphoteric and / or cationic polymers preferred according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers:
  • R -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 3 R 4 R 5 A (_) (monol)
  • R and R 2 independently of one another represent hydrogen or a methyl group and R 3 , R 4 and R 5 independently of one another represent alkyl groups having 1 to 4 carbon atoms, Z denotes an NH group or an oxygen atom, n denotes an integer of 2 to 5 and A ⁇ _) is the anion of an organic or inorganic acid,
  • R 6 and R 7 independently of one another represent a (C 1 to C 4 ) -alkyl group, in particular a methyl group and
  • a cationic group of the amphoteric or cationic polymers is derived from the monomer of the formula (monol)
  • the radicals R 3 , R 4 and R 5 in formula (monol) are preferably methyl groups
  • Z is preferably an NH group
  • a ⁇ _) preferably denotes a halide, methoxysulfate or ethoxysulfate ion. It is particularly preferred in this case to use acrylamidopropyltrimethylammonium chloride as the monomer (monol).
  • a " preferably represents a halide ion, in particular chloride or bromide
  • Preferred amphoteric polymers according to the invention are polymers whose anionic group is derived from at least one monomer of the formula (mono 3)
  • R 8 -CH CR 9 -COOH (mono 3)
  • R 8 and R 9 are independently hydrogen or methyl groups.
  • amphoteric polymers As the monomer (Mono3) acrylic acid is used for the inventively preferred amphoteric polymers.
  • Particularly preferred amphoteric polymers are copolymers of at least one monomer (monol) or (mono 2) with the monomer (mono 3), in particular copolymers of the monomers (mono 2) and (mono 3).
  • Very particularly preferably used according to the invention amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ® 280 (Nalco).
  • amphoteric polymers according to the invention may additionally contain one monomer (mono 4).
  • R 0 -CH CR-C-NH-R 12 (mono 4)
  • R 0 and R independently of one another are hydrogen or methyl groups and R 2 is a hydrogen atom or a (C 1 to C 8 ) alkyl group.
  • Amphoteric polymers based on a comonomer (Mono4) which are very particularly preferably used according to the invention are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).
  • amphoteric polymers are those polymers which are composed essentially
  • R -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 2 R 3 R 4 A (_) (monol)
  • R and R 2 independently of one another represent hydrogen or a methyl group and R 3 , R 4 and R 5 independently of one another represent alkyl groups having 1 to 4 carbon atoms, Z denotes an NH group or an oxygen atom, n denotes an integer of 2 to 5 and A ⁇ _) is the anion of an organic or inorganic acid and
  • R 8 -CH CR 9 -COOH (mono 3)
  • R 8 and R 9 are independently hydrogen or methyl groups.
  • the amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
  • the amphoteric polymers are contained in the agents according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Amounts of 0.01 to 5 wt .-% are particularly preferred.
  • the preferred cationic polymeric compounds according to the invention are in particular selected from the cationic celluloses, the cationic guar derivatives, the cationic starches and the Salcare types and the Merquat types.
  • the most preferred cationic polymeric compounds are Polyquaternium-37, Polyquaternium-80, Polyquaternium-22, Polyquaternium-10, Polyquaternium-11 and Polyquaternium-16.
  • At least one of the aforementioned cationic polymeric compounds is used as the ingredient in each case.
  • the embodiments are most preferred when polyquaternium-37 or polyquaternium-10 or both are used together as the cationic polymer.
  • cosmetic oils can additionally be used with the active ingredient combination (A) according to the invention.
  • these oil bodies have a melting point less than 50 ° C, more preferably less than 45 ° C, most preferably less than 40 ° C, most preferably less than 35 ° C and most preferably the cosmetic oils at a temperature less than 30 ° C flowable.
  • these oils are defined and described in more detail.
  • the natural and synthetic cosmetic oils include, for example:
  • oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, safflower oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn pulp oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • the amount used of the natural and synthetic cosmetic oil bodies in the compositions used according to the invention is usually 0, 1-30 wt.%, Based on the total agent, preferably 0.1 to 20 wt .-%, and in particular 0, 1-15 wt. -%.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances.
  • agent is a hair conditioning composition
  • cationic and / or nonionic surfactants are preferably selected as surfactants.
  • the surfactants essentially comprise two groups, the surfactants and the emulsifiers, which are treated together here.
  • Suitable anionic surfactants and emulsifiers (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body.
  • Typical examples of particularly preferred anionic surfactants are:
  • Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group, alkyl sulfates and / or alkyl ether sulfates,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 2 is hydrogen, a radical (CH 2 CH 2 0) n R 2 or X, n is from 1 to 10 and X is hydrogen, an alkali or Alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical,
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • R 8 CO is a linear acyl radical having 8 to 18 carbon atoms
  • Such products are obtainable, for example, by the company Chem Y under the product name Akypo ®.
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a C8-C30 fatty acid are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® long been commercially.
  • Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines, such as the N-alkyl-N, N-dimethylammonium glycinates, for example the cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example the cocoacylaminopropyl- Dimethylammoniumglycinat, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazoline having in each case 8 to 18 carbon atoms in the alkyl or acyl group and the Kokosacyl- aminoethylhydroxyethylcarboxymethylglycinat.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Ampholytic surfactants and emulsifiers are understood to mean those surface-active compounds which are capable of forming internal salts.
  • suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsaccharides.
  • cosine, 2-Alkylaminopropion Acid and Alkylaminoessigklaroy each having about 8 to 24 carbon atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • ampholytic surfactants and emulsifiers are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and the d 2 -C 8 -acylsarcosine.
  • Nonionic surfactants (Tnio) and nonionic emulsifiers are, for example
  • cationic surfactants besides the cationic compounds according to claim 1 a), all cationic surfactants known and customary to the person skilled in the art can be used according to the invention. These are in particular
  • R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 1 to 35 carbon atoms in the chain, X is -O- or -NR 5
  • R is an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution,
  • R 2 , R 3 each independently represent an alkyl or hydroxyalkyl group having 1 to 6 C atoms in the chain, which chain may be straight or branched.
  • R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxy group.
  • the compounds of one of the following structures are preferably used: CH 3 (CH 2 ) 2 oCONH (CH 2 ) 3 - N + (CH 3 ) 2 -CH 2 CH 3 A " (Tkat-3) CH3 (CH2) 2oCONH (CH2) 3 - N + (CH3) 2-CH2 (CHOH) CH 2 OH A "(Tkat-4)
  • Esterquats be used according to the formula (Tkat1-2).
  • radicals R1, R2 and R3 are each independently and may be the same or different.
  • the radicals R1, R2 and R3 mean:
  • branched or unbranched alkyl radical having 1 to 4 carbon atoms, which may contain at least one hydroxyl group, or
  • aryl or alkaryl radical for example phenyl or benzyl
  • A stands for:
  • n 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl, and R 4 stands for:
  • R6-0-CO- wherein R6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated, or
  • R7-CO- wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units can be ethoxylated, and Q stands for a physiologically compatible organic or inorganic anion.
  • Such products are marketed under the trademarks Rewoquat ®, Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • Tkat1 -2) which are particularly preferred according to the invention include the formula (Tkat1-2.1), the cationic betaine esters.
  • R8 corresponds in its meaning R7.
  • Monoalkyltrimethylammonium salts having a chain length of the alkyl radical of 16 to 24 carbon atoms corresponding to the formula (Tkat1-1),
  • R 1, R 2 and R 3 are each a methyl group and R 4 is a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms.
  • R 1-1 examples of compounds of the formula (Tkat1-1) are cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, stearyltrimethylammonium chloride, behenyltrimethylammonium chloride, behenyltrimethylammonium bromide and
  • Behenyl trimethyl ammonium methosulfate is used in highly preferred erfingusnizaen compositions together with a cationic compound according to claim 1 a) in amounts as described below.
  • Amines and / or cationized amines in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:
  • R 1 is an acyl or alkyl radical having 6 to 30 C atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and
  • R 2, R 3 and R 4 are each independently hydrogen or an alkyl group having 1 to 4 C atoms, which may be the same or different, saturated or unsaturated, and X "is an anion and n is an integer between 1 and 10.
  • X is an anion and n is an integer between 1 and 10.
  • Preference is given to a composition in which the amine and / or the quaternized amine according to general formulas (Tkat7) and / or (Tkat8) is an amidoamine and / or a quaternized amidoamine, in which R1 is a branched or unbranched, saturated or unsaturated acyl radical with 6 to 30 carbon atoms, which may contain at least one OH group means.
  • a fatty acid radical of oils and waxes in particular of natural oils and waxes.
  • oils and waxes examples include lanolin, bees or candellila waxes.
  • amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkat8) represent a radical according to the general formula CH 2 CH 2 OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
  • the preferred size of n in the general formulas (Tkat7) and / or (Tkat8) is an integer between 2 and 5.
  • amidoamines and / or quaternized amidoamines of the general formulas (Tkat7) and / or (Tkat8) in wherein the anion X "is a halide ion or a compound of the general formula RS ⁇ 3 " , wherein R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms.
  • the alkyl group having 1 to 4 carbon atoms of R2, R3 and R4 and / or alkyl having 1 to 4 carbon atoms of RSO 3 "in the general formula (Tkat7) and / or (Tkat8) may contain at least one hydroxyl group.
  • the alkylamidoamines can both The cationic alkylamidoamines are preferred according to the invention.
  • the amidoamines to be used according to the invention which may optionally be quaternized, are, for example, amidoamines: Witcamine.RTM.
  • Rewoquat® RTM 50 Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen® CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol® Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat ® UTM 50 (Witco Surfactants GmbH, Undecyleneamidopropyltrimonium Methosul
  • the anion of all of the previously described cationic compounds is selected from the physiologically acceptable anions.
  • exemplary of these are the halide ions, fluoride, chloride, bromide, sulfate of the general formula RS ⁇ 3 " , in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids such as maleate, fumarate, oxalate, tartrate, Citrate, lactate or acetate, called.
  • the aforementioned cationic surfactants can be used individually or in any combination with each other, wherein amounts between 0.01 to 20 wt.%, Preferably in amounts of 0.01 to 10 wt.% And most preferably in amounts of 0.1 to 7.5% by weight. The very best results are obtained with amounts of 0, 1 to 5 wt.%, In each case based on the total composition of the respective agent.
  • the surfactants (T) are used in a total amount of the surfactants in amounts of 0.05-45% by weight, preferably 0-1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total used according to the invention.
  • compositions according to the invention according to claim 1 further contain at least one carbohydrate, a sugar alcohol or sugar.
  • monosaccharides, disaccharides, trisaccharides and oligosaccharides, aminodeoxysugars, deoxysugar thiosugars are advantageous.
  • monosaccharides having 3 to 8 C atoms such as trioses, tetroses, pentoses, hexoses, heptoses and octoses.
  • most preferred are oligosaccharides having up to 50 monomer units.
  • Examples include sorbitol, inositol, mannitol, tetrite, pentite, hexite, threitol, erythritol, adonite, arabitol, xylitol, dulcitol, erythrose, threose, arabinose, ribose, xylose, lyxose, glucose, galactose, mannose, allose, altrose, gulose , Idose, talose, fructose, sorbose, psicose, tegatose, deoxyribose, glucosamine, galactosamine, rhamnose, digitoxose, thioglucose, sucrose, trehalose, lactose, maltose, cellobiose, melibiose, gestiobiose, rutinose, raffinose
  • Preferred carbohydrates are sorbitol, inositol, mannitol, threitol, erythrose, erythrose, threose, arabinose, ribose, xylose, glucose, galactose, mannose, allose, fructose, sorbose, deoxyribose, glucosamine, galactosamine, sucrose, trehalose, maltose and cellobiose.
  • Particular preference is given to using glucose, galactose, mannose, fructose, deoxyribose, glucosamine, sucrose, maltose and cellobiose.
  • glucose, galactose, lactose, mannose, fructose, sucrose, maltose or cellobiose is very particularly preferred.
  • compositions according to the invention which, based on the weight of the composition, contain 0.01 to 5% by weight, preferably 0.05 to 4% by weight, particularly preferably 0.05 to 3.5% by weight. % and in particular 0, 1 to 2.5 wt.% Carbohydrate.
  • compositions according to the invention according to claim 1 furthermore contain vitamins, provitamins or vitamin precursors in the compositions.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • vitamin A The group of substances referred to as vitamin A include retinol (vitamin A-1) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A acid and its esters vitamin A aldehyde and vitamin A alcohol, as well as its esters, such as palmitate and acetate, come into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone. Panthenol and / or pantolactone are preferably used in the context of this group.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives.
  • the said compounds of the vitamin B 5 type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0, 1-5 wt .-% are particularly preferred.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
  • the vitamins of the B series and of the B5 series are particularly preferred from the vitamins of the B series.
  • Vitamin C (ascorbic acid). Vitamin C is used in the inventive compositions preferably in amounts of 0, 1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferred in the agents according to the invention in amounts of from 0.0001 to
  • compositions according to the invention preferably contain vitamins, provitamins and
  • Vitamin precursors from groups A, B, E and H. Vitamin B, and biotin are most preferred.
  • the adjustment of the viscosity of the compositions according to the invention can be carried out with all raw materials known for this purpose. However, it is preferred according to the invention for the adjustment of the viscosity in particular to choose nonionic polymers on a natural basis. These are in particular xanthan gum, for example Keltrol® types, guar gum, gelatine, pectins, starches, for example from potatoes, rice or maize. In particular, the starch is used in a pre-gelatinized form. Such products are commercially available from Avebe, Hercules, National Starch and others.
  • the nonionic polymers on a natural basis are present in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5% by weight, particularly preferably from 0.05 to 5.0% by weight, in each case included on the weight of the entire composition.
  • compositions according to claim 1 may be any other ingredients customary in cosmetic products. The skilled person will select these depending on the purpose of the agent targeted. In the following, some very particularly preferred further ingredients are described by way of example.
  • the first group of other ingredients are plant extracts.
  • the plant extracts can be used according to the invention both in pure and in diluted form. Based on the content of the respective plant extract, plant extracts are used in amounts such that in the compositions according to the invention active ingredient contents of the respective extract are in an amount of 0.001 to 7.5 Wt.%, Preferably 0.01 to 5.0 wt.% And particularly preferably from 0.01 to 3.0 wt.% Are included.
  • protein hydrolysates can be used.
  • protein hydrolysates of both plant and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda), Crotein ® (Croda) and Puricare ® LS 9658 from Laboratoires Serobi unanimouss.
  • protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
  • the protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.
  • a particularly preferred group of ingredients in the cosmetic compositions according to the invention are the following betaines: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, betalain, 1, 1-dimethyl-proline, choline, choline chloride, choline bitartrate, choline dihydrogen citrate and in the literature as Betaine designated compound ⁇ , ⁇ , ⁇ -trimethylglycine.
  • Carnitine, histidine, choline and betaine are preferably used.
  • the active ingredient used is L-carnitine tartrate.
  • agents which, based on their weight, contain from 0.00001 to 10.0% by weight, preferably from 0.0001 to 5.0% by weight and in particular from 0.001 to 3% by weight, of the betaines mentioned ,
  • taurine is exclusively 2-aminoethanesulfonic acid and a derivative is understood to mean the explicitly mentioned derivatives of taurine.
  • Derivatives of taurine include N-monomethyltaurine, N, N-dimethyltaurine, tauryllysylate, taurine tartrate, taurine ornithithate, lysyl taurine and ornithyl taurine.
  • Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
  • agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included.
  • the compositions according to the invention contain biochinones.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the preferred ubiquinones according to the invention have the following formula:
  • Coenzyme Q-10 is most preferred.
  • compositions of the invention contain purine and / or purine derivatives in narrower ranges.
  • preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of preferred compositions according to the invention contain purine and / or purine derivatives in narrower quantitative ranges.
  • preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • Cosmetic agents preferred according to the invention are characterized in that they contain at least one of the following purines: purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine or theophylline.
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the composition) can be used.
  • fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, Palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic, elaeostearic, arachidic, gadoleic, behenic and erucic acids and their technical mixtures.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0, 1-15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • fatty alcohols fatal
  • saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 -, preferably C 10 -C 22 -and very particularly preferably C 12 -C 22 -carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Is
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of 0.1 to 30% by weight, based on the total preparation, preferably in amounts of 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • UV light protection filters with an effect in the range of UV-A, UV-B and UV-C light both as water-soluble and oil-soluble filters
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), or ZEA Structure®, multifunctional, salt tolerant starches;
  • Coupler and developer type dye precursors are Coupler and developer type dye precursors
  • Structurants such as maleic acid and lactic acid
  • Swelling agents such as urea, allantoin, carbonates or hydantoin
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, C0 2 and air,
  • the high care effect of the agents according to the invention is of particular importance, in particular, since it gives excellent results even in the presence of oxidizing agents, for example in the context of oxidative hair dyeing.
  • a second subject of the invention is a method for hair treatment, in which a cosmetic agent according to claim 1 is applied to the hair and remains on the hair until the next hair wash.
  • the hair may be styled and styled after applying the composition of the invention by any conventional means.
  • the application of heat in the form of a hair dryer, a towel, a drying hood or a curling iron or curler is possible.
  • other styling of the hair supporting compositions such as a hair spray can be used here.
  • the composition of the invention can remain on the hair for up to 30 minutes after a few seconds and then be rinsed out again.
  • the composition according to claim 1 is formulated as a spray application.
  • a viscosity of 2000 to 25,000 mPas measured at room temperature (23 ° C.) according to Brookfield with spindle 4 is preferably set. Adjusting the viscosity is familiar to the person skilled in the art. For this purpose, for example, conventional polymeric compounds, as described above, used. But other common methods are possible. Particularly preferred is a viscosity of 5000 mPas to 15000 mPas and most preferably from 5000 to 10000 mPas. These viscosities are measured as previously mentioned.
  • the spray pump When packaging in the present invention preferred dosage form as a non-aerosol spray application in particular the spray head, the spray pump must be particularly adapted to the viscosity properties of the composition. Otherwise, too much of the composition is applied, or the spray pattern is too coarse and poorly dispersed on the hair, or the spray is far too fine, which also adversely affects the effect of the composition.
  • a specific spray pump is selectively selected depending on the viscosity range of the composition according to the invention. If necessary, the pump characteristics, such as the inner diameter of the nozzle, the stroke of the pump, the volume of the piston, the length of the riser, the geometry of the nozzle, etc must be adjusted.
  • a third object of the present invention is therefore a non-aerosol composition for treating keratin fibers containing
  • a cosmetic carrier comprising, in addition to water, an alcohol selected from glycol, glycerol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,6-hexanediol, benzyl alcohol, phenoxyethanol or mixtures thereof,
  • composition has a viscosity of 5000 to 10,000 mPas at 20 ° C measured according to Brookfield with spindle 5, and e) in a container which is large enough so that with the help of a 150 ml long riser the content of a spray pump, which with a nozzle with a diameter of max. 0.25 mm is applied.
  • Nicotinic acid amide 0, 15
  • Amaranth powder (85%) 0.0001 0.0001
  • Lactic acid (80%) 1, 13 0.2 0.25
  • the formula E6 according to the invention is assessed much better in all parameters.
  • the long-term effect, the wet hair grip, the static charge and the spray behavior were significantly improved.
  • composition according to the invention is in turn clearly superior to the comparative composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des agents de traitement capillaire renfermant des alcools sélectionnés et des silicones sélectionnées, ainsi que l'utilisation de ces agents pour traiter des cheveux. Ces agents sont de préférence conçus pour une application par vaporisateur non aérosol.
EP11720809.0A 2010-07-14 2011-05-24 Compositions de conditionnement capillaire Withdrawn EP2593189A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010031318A DE102010031318A1 (de) 2010-07-14 2010-07-14 Haarkonditionierende Zusammensetzungen
PCT/EP2011/058446 WO2012007214A2 (fr) 2010-07-14 2011-05-24 Compositions de conditionnement capillaire

Publications (1)

Publication Number Publication Date
EP2593189A2 true EP2593189A2 (fr) 2013-05-22

Family

ID=44626507

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11720809.0A Withdrawn EP2593189A2 (fr) 2010-07-14 2011-05-24 Compositions de conditionnement capillaire

Country Status (4)

Country Link
US (1) US20130125914A1 (fr)
EP (1) EP2593189A2 (fr)
DE (1) DE102010031318A1 (fr)
WO (1) WO2012007214A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA028139B1 (ru) * 2012-08-06 2017-10-31 Юнилевер Н.В. Композиция шампуня
DE102012214046A1 (de) * 2012-08-08 2014-02-13 Henkel Ag & Co. Kgaa Einphasiges transparentes Haargel
DE102012215799A1 (de) * 2012-09-06 2014-03-06 Henkel Ag & Co. Kgaa Haarpflegemittel mit gesteigerten Pflegeleistungen
DE102012222769A1 (de) * 2012-12-11 2014-06-12 Henkel Ag & Co. Kgaa Haarpflegemittel mit Silikonen enthaltend Zuckerstrukturen und ausgewählte weitere Silikone
FR3024055B1 (fr) * 2014-07-25 2021-07-02 Aptar France Sas Organe de distribution de produit fluide.
US20180085291A1 (en) * 2016-09-28 2018-03-29 International Flavors & Fragrances Inc. Microcapsule compositions containing amino silicone
US20210154116A1 (en) * 2019-11-27 2021-05-27 L'oreal Compositions and methods for hair
US11826451B2 (en) 2019-12-31 2023-11-28 L'oreal Compositions for treating hair
US12109289B2 (en) 2021-06-30 2024-10-08 L'oreal Compositions for imparting color and tone to the hair
US12036299B2 (en) 2021-06-30 2024-07-16 L'oreal Compositions containing direct dyes for imparting color and tone to the hair
US12109287B2 (en) 2022-07-31 2024-10-08 L'oreal Compositions and methods for altering the color of hair

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004037397A1 (de) * 2004-07-30 2006-03-23 Henkel Kgaa Haarkonditionierende Mittel mit Imidazolinen und aminofunktionellen Siliconen
DE102007060528A1 (de) * 2007-12-13 2009-06-18 Henkel Ag & Co. Kgaa Haarkonditionierende Mittel mit Imidazolinen und ausgewählten Siliconen und/oder kosmetischen Ölen
DE102008037633A1 (de) * 2008-08-14 2010-02-18 Henkel Ag & Co. Kgaa Kosmetische Zusammensetzung enthaltend Öl aus den Früchten der Sumachgewächse

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012007214A2 *

Also Published As

Publication number Publication date
DE102010031318A1 (de) 2012-01-19
WO2012007214A3 (fr) 2013-08-29
US20130125914A1 (en) 2013-05-23
WO2012007214A2 (fr) 2012-01-19

Similar Documents

Publication Publication Date Title
EP2165697A1 (fr) Compositions de réduction de la rupture de fibres kératiniques
EP2593189A2 (fr) Compositions de conditionnement capillaire
EP2528582A2 (fr) Produits de conditionnement capillaire contenant des silicones cationiques et de la diméthicone
WO2010018047A2 (fr) Composition cosmétique contenant des huiles issues des fruits du sumac
DE102012203240A1 (de) Haarpflegemittel mit Antischuppenmitteln und ausgewählten Aminosilikonen
WO2013143776A2 (fr) Agents de traitement capillaire contenant des amides d'acides gras sélectionnés et des composés d'ammoniums quaternaires sélectionnés
WO2013072163A2 (fr) Produit de soin capillaire doté d'agents antipelliculaires et de silicones cationiques
EP2830581A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des filtres uv sélectionnés
WO2011009710A2 (fr) Produits de conditionnement capillaire contenant des imidazolines cationiques et des silicones cationiques sélectionnées
EP2830577A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des corps gras sélectionnés
EP2464329A2 (fr) Compositions pour soins capillaires contenant de l huile de ramboutan
WO2013143780A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des silicones sélectionnés
WO2013143738A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des acides hydroxycarboxyliques sélectionnés
WO2013143735A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des composés d'ammonium quaternaire
EP2606936B1 (fr) Procédé de soin capillaire avec un produit de soin comprenant un émulsifiant spécial et des hydrolysats protéiques
EP2822658A2 (fr) Produit de cure capillaire exempt de silicones arylées
DE102012219587A1 (de) Klares Pflegespray mit gesteigerter Leistung
EP2571480A2 (fr) Produit de traitement capillaire contenant du polyquaternium-72
WO2011020646A2 (fr) Compositions de soin capillaire contenant de l'alcool lanolique à teneur élevée en alcools gras à longue chaîne
DE102013226423A1 (de) Haarbehandlungsmittel mit spezieller Konditioniermittelkombination
WO2013113563A2 (fr) Produits capillaires contenant des alkyloligoglucosides cationiques sélectionnés et d'autres composés d'ammonium quaternaires
WO2013072156A2 (fr) Produit de soins capillaires contenant des composés cationiques sélectionnés et des silicones cationiques
EP2785318A2 (fr) Soin capillaire contenant du polyquaternium-71 et des silicones cationiques
WO2011009711A2 (fr) Produits de conditionnement capillaire contenant des silicones cationiques sélectionnées et une vitamine de la série b
WO2014023491A2 (fr) Agents de soins capillaires contenant des composés ammonium quaternaires choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121210

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

R17D Deferred search report published (corrected)

Effective date: 20130829

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140318